Baudax Bio Inc (BXRXQ)
OTCMKTS: BXRXQ · Delayed Price · USD
+0.0020 (25.00%)
May 24, 2024, 4:00 PM EDT - Market closed

Baudax Bio Statistics

Total Valuation

Baudax Bio has a market cap or net worth of $79,935. The enterprise value is $7.81 million.

Market Cap 79,935
Enterprise Value 7.81M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Baudax Bio has 7.99 million shares outstanding. The number of shares has increased by 2,601.40% in one year.

Shares Outstanding 7.99M
Shares Change (YoY) +2,601.40%
Shares Change (QoQ) +63.63%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

The trailing PE ratio is 0.00.

PE Ratio 0.00
Forward PE n/a
PS Ratio 0.26
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 25.21
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.07

Current Ratio 0.07
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -48.50%
Return on Capital (ROIC) n/a
Revenue Per Employee $34,444
Profits Per Employee -$795,000
Employee Count 9
Asset Turnover 0.02
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -98.17% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change -98.17%
50-Day Moving Average 0.01
200-Day Moving Average 0.14
Relative Strength Index (RSI) 48.87
Average Volume (30 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Baudax Bio had revenue of $310,000 and -$7.16 million in losses.

Revenue 310,000
Gross Profit -4.48M
Operating Income -24.37M
Pretax Income -7.16M
Net Income -7.16M
EBIT -7.16M
Earnings Per Share (EPS) $83.80
Full Income Statement

Balance Sheet

The company has $363,000 in cash and $8.10 million in debt, giving a net cash position of -$7.73 million or -$0.97 per share.

Cash & Cash Equivalents 363,000
Total Debt 8.10M
Net Cash -7.73M
Net Cash Per Share -$0.97
Equity / Book Value -10.24M
Book Value Per Share -1.28
Working Capital -17.71M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$4.63 million and capital expenditures -$21,000, giving a free cash flow of -$4.65 million.

Operating Cash Flow -4.63M
Capital Expenditures -21,000
Free Cash Flow -4.65M
FCF Per Share -$0.58
Full Cash Flow Statement


Gross margin is -1,445.81%, with operating and profit margins of -7,860.32% and -2,308.06%.

Gross Margin -1,445.81%
Operating Margin -7,860.32%
Pretax Margin -2,308.06%
Profit Margin -2,308.06%
EBITDA Margin -2,230.65%
EBIT Margin -2,308.06%
FCF Margin -1,499.03%

Dividends & Yields

Baudax Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2,601.40%
Shareholder Yield -2,601.40%
Earnings Yield -8,951.00%
FCF Yield -5,813.46%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) 136.94%
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Baudax Bio has an Altman Z-Score of -15.04 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -15.04
Piotroski F-Score 2